You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ackerman S, Hartmann F, Pearson C, et al
603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0603